To review and summarize the literature on the normal venous circulation of the leg, and the epidemiology, pathophysiology, and treatment of chronic venous insufficiency (CVI).
pproximately 5 million people in the United States exhibit some evidence of chronic venous insufficiency (CVI) and between 400,000 and 500,000 of these individuals have or will develop a venous leg ulcer. [1] [2] [3] The signs of CVI include engorgement of the cutaneous veins and dependent edema in mildly affected patients to pigmentation, dermatitis, and ulceration in the more severe cases. Although most patients are asymptomatic, others have leg heaviness and aching or recurrent and recalcitrant leg ulcers punctuated by bouts of cellulitis. These more severe cases are associated with recurrent hospitalization, high health-care costs, and disability. 4, 5 Venous insufficiency with trophic skin changes or ulceration is a frustrating problem, which many physicians approach with a sense of ennui. This may be due to the chronic and remitting nature of the problem, the need for lifestyle modification, inconvenient therapies, and contradictory information regarding medical and surgical management. Nevertheless, CVI, including ulceration, is a manageable problem. The purpose of this review is to present the normal anatomy and physiology of the venous circulation and to summarize the epidemiology, pathophysiology, and treatment of CVI.
METHODS
A MEDLINE search for relevant English-language articles published between 1966 and 1996 was completed using the following MeSH terms: venous insufficiency or varicose ulcer and epidemiology, pathophysiology, diagnosis, and clinical trial (pt). When selecting articles on treatment, randomized, controlled trials were reviewed whenever possible. Emphasis was placed on reviewing articles with clinical relevance for internal medicine physicians.
ANATOMY AND NORMAL PHYSIOLOGY
Venous blood from the skin and subcutaneous fat is collected in a system of superficial venules and veins that drain toward the deep venous system underneath the fascia via three major pathways: (1) through the long or short saphenous veins, which join the deep system at the saphenofemoral and saphenopopliteal junctions; (2) through the perforating veins originating from the long or short saphenous veins or their branches; or (3) directly into the deep venous system or bypass the deep system entirely and enter the pelvis. 6 Deep veins are categorized as either intramuscular or intermuscular; of the two, the intermuscular veins are of greater importance in CVI. 7 Intermuscular veins are three paired veins named after the artery they accompany; the posterior tibial vein originates behind the medial malleolus, the anterior tibial vein originates in the dorsum of the foot, and the peroneal vein is found between the tibia and fibula. These three paired veins join to form the popliteal vein in the popliteal space. The popliteal vein enters the thigh to become the superficial femoral vein, and a few centimeters below the saphenofemoral-femoral junction, it is joined by the deep femoral vein to form the common femoral vein. After passing beneath the inguinal ligament to enter the pelvis, the femoral vein is renamed the common iliac vein, and on joining the contralateral common iliac, it becomes the inferior vena cava.
Venous valves are generally bicuspid in nature, and they direct flow from the superficial system to the deep and from the distal to the proximal deep veins. Generally, there are more valves distally where the hydrostatic pressure is the greatest. 7 Blood is moved from the leg toward the heart primarily by the pumping action of the leg muscles. 8 As blood is expelled from the deep system by muscular contraction, it is drawn from the superficial to the deep system, thereby lowering the superficial venous pressure. Competent valves are required to prevent regurgitation during muscle relaxation, and to protect the superficial veins and capillaries from the sudden rise in venous pressure. 9 Normally, the venous pressure in the superficial system during ambulation is between 20 and 30 torr; pressures higher than this constitute venous hypertension, the main predisposing factor in CVI. [9] [10] [11] [12] 
CLINICAL PRESENTATION
The most frequently encountered form of CVI is the varicose vein. The size of varicose veins may range from a submalleolar venous flare to various degrees of vessel dilation apparent by palpation and observation. Further progressive changes of CVI include a tan or reddishbrown hue to the skin, particularly at the medial ankle (Fig. 1) . In more advanced cases the skin may have small erosions with weeping and excoriations due to scratching. There may be crusting which can be aggravated by sensitization to applied topical medications. With sufficient severity and chronicity, patients may develop lipodermatosclerosis, a fibrosing panniculitis of the leg. This can be felt as a firm induration at the medial ankle, and in the most advanced cases, found to extend circumferentially up to the mid-leg. The skin overlying the panniculitis is heavily pigmented and bound down to the subcutaneous tissues. Fibrosis may be so extensive and constrictive as to girdle the lower third of the leg resulting in a brawny edema above the fibrosis and on the foot below. In this respect, an advanced case of lipodermatosclerosis resembles an inverted champagne bottle-the bulbous cork representing the edematous foot, the narrow bottle neck the area of lipodermatosclerosis, and the body of the bottle the edematous leg (Fig. 2) . Within the areas of heavy pigmentation are 2-to 5-mm macules of depigmentation, atrophie blanche, which represent avascular, fibrotic skin and are thought to predispose to ulcer formation (Fig. 3) . 12 Venous ulcers tend to occur on the medial ankle, in the area of lipodermatosclerosis. They may be single or multiple, and are typically tender, shallow, and have a red base that may be exudative (Fig. 4) . The borders are irregular and not undermined, but if left unattended, the ulcer may extend to cover the entire circumference of the leg. 13, 14 New guidelines for the classification and grading of CVI, published in 1996, 15 may be helpful for documenting the severity of disease and communicating the results of clinical trials.
EPIDEMIOLOGY AND NATURAL HISTORY
In the Tecumseh Community Health Study, the prevalence of edema, trophic skin changes, or ulceration related to CVI was found to be 2%. 1 Other cross-sectional studies have estimated the prevalence of active venous FIGURE 1. Characteristic changes of chronic venous insufficiency consisting of red and blue-brown pigmentation, and dry scaly skin. JGIM ulcers in the community to be between 0.06% and 1%. 3, 5, [16] [17] [18] These same studies have confirmed that leg ulcers are slightly more common in women, particularly in the older age groups, and there is a marked increase with advancing age. Venous ulcers are chronic and recurrent; according to patient recall, up to 50% of venous ulcers may be present for 7 to 9 months, between 8% and 34% may be present for more than 5 years, and between 67% and 75% of patients have recurrent ulcers. 18, 19 The association of deep venous thrombosis (DVT) with chronic leg edema, pigmentation, and ulceration is well established as the "postphlebitic syndrome." Several uncontrolled, prospective studies have examined the relation between DVT and the development of CVI. These studies report the occurrence of edema in about two thirds of patients, skin pigmentation in one third, and venous ulceration in about 4%. [20] [21] [22] [23] Trophic skin changes tend to occur between 2 and 4 years after the diagnosis of DVT, with no further changes between 5 and 12 years. 21 In general, the absolute risk of trophic skin changes appears to be greatest with proximal thrombosis, as compared with distal thrombosis, and with deep, or deep and superficial thrombosis, as compared with superficial thrombosis. 20, 22, [24] [25] [26] [27] [28] These studies have also correlated the severity of skin changes to the number of thrombosed venous segments, and the degree of venous reflux.
In one prosecutive, controlled study, patients with proximal DVT had more pigmentation and pitting edema than control subjects or patients with distal DVT; however, symptoms of aching pain, morning swelling, itching, or the need to wear compression stockings were not different among the three groups. 29 Some caution is needed in interpreting the findings as 64% of the original cohort group was lost to follow-up.
Despite its well-recognized association, the attributable risk of DVT for CVI cannot be calculated owing to lack of suitable controlled, prospective studies. There is information suggesting that conditions other than DVT may produce CVI. In some studies, fewer than one third of the patients have a history compatible with DVT or phlebitis, and in others, no more than 50% of patients with CVI have postthrombotic changes noted on venography. 19, 24, 30 In addition, up to 40% of patients with DVT will develop signs of CVI in the opposite, uninvolved limb. 22 Other conditions that may be important in the development of CVI include previous leg injury or surgery, primary valve or venous wall degeneration, congenital absence of valves, and arteriovenous shunts. 11, 12 
PATHOPHYSIOLOGY
Whatever the cause of venous insufficiency, the end result is venous hypertension. The normal pressure in the superficial leg veins during exercise is maintained between 20 and 30 torr by the action of the calf-muscle pump and competent venous valves, but progressively increases to 60 to 90 torr in the presence of valvular incompetence or venous obstruction. [9] [10] [11] 31 The deleterious effect of venous hypertension in CVI is aggravated by loss of the normal reflexive constriction of the precapillary arterioles during standing, which helps protect the capillary bed from surges in hydrostatic pressure. 32 In these patients, exaggerated pressures are transmitted directly to the capillary network of the skin. 10, 33 Sustained hypertension at the capillary level is associated with many morphologic changes including elongation and dilation of the capillary bed, increased surface area of the endothelium, increased type IV collagen in the basement membrane, and the formation of a pericapillary fibrin cuff. 12, [34] [35] [36] [37] These abnormal capillaries are more permeable to large molecules, including fibrinogen, 38 and it has been hypothesized that leaked fibrinogen is converted to fibrin in the pericapillary space. 37, 38 Other studies have shown that the fibrinolytic activity of blood and tissues is deficient in patients with lipodermatosclerosis, resulting in a decreased clearance of fibrin. [38] [39] [40] Although the functional significance of pericapillary fibrin is debated, studies in patients with lipodermatosclerosis have documented diminished cutaneous oxygenation, 34, 41, 42 which improves with the administration of oxygen, 43 suggesting that a diffusion barrier, rather than deficient transport, is responsible for low oxygen tissue pressure.
Other changes in the microcirculation include fragmentation and obliteration of the cutaneous lymphatic network and decreased lymphatic flow. These changes appear to be correlated with the severity of the venous hypertension, [44] [45] [46] and may contribute to the local edema and inflammation associated with CVI.
Rheologic disorders have also been associated with venous hypertension. Low shear stresses are associated with erythrocyte aggregation, and the lowest shear stresses are found in association with the highest venous pressures. 47, 48 Erythrocyte aggregation reduces oxygen transport capacity, slows arteriolar circulation, and enlarges the capillary spaces. 47 Leukocytes also aggregate in capillary beds with low shear stresses and may activate, releasing proteolytic enzymes, resulting in increased capillary permeability and local inflammatory changes. [49] [50] [51] 
DIAGNOSTIC TESTING
Diagnostic testing serves to confirm the diagnosis of venous insufficiency, to ascertain its etiology (reflux or obstruction), and to localize the anatomic site and level of disease. Among the variety of functional and imaging tests available, duplex ultrasonography is regarded as the method of choice because it is accurate, reproducible, and noninvasive. 28, 52 Duplex ultrasonography of the leg consists of real-time, B-mode imaging of the deep and superficial veins combined with directional pulsed Doppler assessment of blood flow. In B-mode imaging, a real-time scanner rapidly and automatically sweeps the ultrasound beam over the area to be imaged and constructs an image from the returned signals and allows for detection of movement in the structures imaged. 53 In contrast, directional pulsed Doppler transducers detect relative motion between the source of the signal and the reflector of the signal.
In peripheral vascular studies, the sources of the reflected signals are red blood cells moving in vessels, and flow analysis can be performed by listening to the audible signal or by recording the spectral analysis of the signal. A computer analysis of the spectral display can determine flow velocity, direction, and characteristics of flow (laminar or turbulent). Combining real-time, B-mode ultrasonography with directional pulsed Doppler can provide 52, 53 A number of studies have demonstrated the accuracy of B-mode ultrasonography or duplex scanning in the diagnosis of DVT. As compared with venography, sensitivity ranges from 86% to 96% and specificity from 80% to 100%, with most errors occurring in the calf or popliteal veins. [54] [55] [56] [57] [58] In the diagnosis of DVT, the criteria with the highest combined sensitivity and specificity, at 92% each, are absence of spontaneous venous flow and absent phasicity of flow with respiration. 57 B-mode ultrasonography also has the advantage of visualizing other anatomic structures in the leg that can produce pain or swelling and mimic venous disease, such as ruptured or dissecting popliteal cysts, soft tissue hematomas, arterial aneurysms, and soft-tissue masses. 58, 59 In the diagnosis of venous reflux, duplex scanning has been shown to be superior to descending venography in correlating with the degree of venous reflux as measured by foot volumetry and with the clinical severity of disease as determined by clinical examination. [60] [61] [62] [63] Duplex scanning is 84% sensitive and 88% specific in the diagnosis of deep venous insufficiency as compared with direct venous pressure measurements and venous filling times. 64 Arterial disease needs to be considered when evaluating patients with lower extremity ulcers. A useful screening test is the ankle-to-brachial blood pressure ratio (the ankle/brachial index or ABI) as measured by Doppler ultrasonography. An ABI of 0.9 or higher is normal; patients with claudication usually have an ABI of 0.5 to 0.9; and in patients with resting ischemic pain, it is usually less than 0.5. 65 Concomitant arterial disease is common in patients with venous ulcers. In one study of 600 patients with chronic leg ulcers, 11% had no palpable ankle or foot pulses, 21% had an ABI of less than 0.9, and 10% had an ABI of less than 0.7. 66 Arterial insufficiency was more likely in older patients, and in those with a history of coronary or cerebrovascular disease, or if the ulcer was on the foot rather than the ankle or leg. The significance of diagnosing arterial insufficiency lies in opportunities for revascularization and avoidance of complications due to inappropriate compression therapy.
MECHANICAL THERAPY
Treatment goals for patients with CVI include reduction of edema, elimination of lipodermatosclerosis, and healing of ulcers. Available treatment options can be divided into mechanical, drug, and surgical. Simple elevation of the legs above heart level for 30 minutes three or four times per day is effective in reducing edema and improving the cutaneous microcirculation in patients with CVI. 67, 68 In more advanced disease, leg elevation alone will not be sufficient, and most experts consider compression stockings an essential treatment modality. 42 69, 79 Compression therapy has also been shown to enhance fibrinolysis, [80] [81] [82] and it may be an important mechanism in reducing fibrosis and promoting ulcer healing.
Randomized, placebo-controlled trials testing the effect of compression on the rate of ulcer healing or regression of lipodermatosclerosis are not available. Cohort studies have suggested that ulcer healing rate, rate of recurrence, and time to first recurrence are significantly improved in patients compliant with compression therapy. [83] [84] [85] To be effective, compression stockings must be capable of exerting 20-30 torr of pressure at the ankle and less at the knee. 69, 86 For most patients, knee-high stockings are sufficient; thighhigh stockings are less desirable due to impedance of venous flow at the popliteal space with knee bending. 69, 86 Assuming proper measurement and fitting of hose, specific instructions on how to put on compression stockings may enhance compliance. Washing new hose before wearing them will reduce some of the initial stiffness. Hose should be applied as soon as possible in the morning when edema is minimal and after ulcers are dressed, as described below. Patients should be instructed to sit on a bed, chair, or floor and have a back support to lean against. Knee-high hose are applied by turning the leg portion of the stocking inside-out to the heel. With the stocking stretched, the foot is slipped inside while simultaneously pulling the stocking by the folded edge. As the stocking is pulled on, it will turn rightside out, and should be gently worked up the leg. Some manufacturers recommend wearing rubber gloves to slide the stocking up the leg rather than grasping and pulling. Heavy compression stockings may go on more easily if a silky, light hose or talcum powder is used first. Many compression stockings without elastic are now available, an important feature for patients with rubber (latex) sensitivity.
Despite these techniques, some patients still do not have the strength or mobility to pull on compression stockings. To accommodate these patients, innovations include stockings with a zippered back (Jobst Ulcer Care), and leggings with a series of interlocking bands fastened with Velcro (CircAid) are now available. These stockings can be particularly useful for patients with bulky ulcer dressings that would be difficult to cover with conventional stockings. Adjustable leggings have the advantage of tightening the interlocking fasteners as edema lessens, or custom-fitting oddly shaped legs.
In patients with massive edema or obesity, standard compression stockings may be ineffective. An alternative approach is the use of intermittent pneumatic compression (IPC) pumps. These devices consist of plastic air chambers that encircle the lower leg; periodically the air chamber fills to a preset pressure, compressing the leg, and then deflates. IPC pumps may consist of a single chamber or multiple chambers that inflate sequentially from the foot to the knee. In a randomized trial, sequential IPC pumps were more effective than single-chamber IPC pumps in clearing venographic dye from the deep venous system and preventing postoperative DVT. 87 In another randomized trial, sequential IPC pumps were superior to compression stockings in the healing of venous ulcers, although the pumped patients may have elevated their legs for a longer period of time, thus confounding the results. 88 Relative contraindications to compression or IPC pumping include arterial insufficiency and uncompensated congestive heart failure. 66 In the treatment of venous ulcers, it is usual practice to cover the ulcer with a dressing before initiating compression therapy. Choices of dressings include dry or wet, nonadherent dressings; occlusive, hydrocolloid dressings (DuoDerm); and zinc-paste-impregnated bandages (Unna boot). Few randomized trials have been performed comparing the dressings, and the choice depends largely on clinical judgment, convenience, and cost. As compared with wet or dry, nonadherent dressings, occlusive hydrocolloidal dressings resulted in a greater reduction in pain but in minimal or no improvement in the ulcer healing rate. [89] [90] [91] [92] [93] Similarly, the rate of ulcer healing was no different in patients treated with Unna boots as compared with occlusive hydrocolloidal dressings, but patients preferred the occlusive dressing because of ease of ulcer care. 92 Unna boots must be applied by trained personnel once or twice per week, whereas occlusive hydrocolloidal dressings can be changed at home by the patient every 3 to 7 days.
DRUG THERAPY
Diuretics may occasionally have a role in the treatment of CVI, but their use should be restricted to a short period of time in patients with severe edema. As in other edematous states not associated with volume overload, the injudicious use of diuretics can lead to hypovolemia and metabolic complications, particularly in the elderly.
Most ulcers are heavily contaminated with bacteria including Staphyloccocus , Streptococcus , Escherichia coli , Proteus , and Pseudomonas , and they tend to remain so despite the use of topical antibiotics. 94 , 95 The use of topical antibiotics in the absence of clinical infection does not appear to be useful and may be harmful owing to the increased susceptibility of contact dermatitis in patients with CVI and emergence of resistant organisms. [94] [95] [96] Routine administrations of systemic antibiotics have not been shown to improve the healing rates of venous ulcers and should be reserved for ulcers that are obviously infected, or are complicated by clinically apparent cellulitis. 96 Topically applied antiseptics, including hydrogen peroxide, povidone-iodine, acetic acid, and sodium hypochlorite, have all been shown to have cellular toxicities that exceed their bactericidal activities, and all except hydrogen peroxide have been found to impair wound epithelialization, [97] [98] [99] and are not recommended.
Accumulation of pus and fibrin may delay the healing of chronic ulcers by preventing granulation and epithelialization. Several enzyme debriding agents are available as well as krill enzymes, which consist of natural endopeptidases and exopeptidases capable of breaking down proteinaceous substrates to soluble free amino acids. Compelling evidence for the use of these enzymes in randomized, controlled studies is lacking. 100 Several growth factors play a role in wound healing, including platelet-derived growth factor (PDGF), epidermal growth factor (EGF), fibroblast growth factors (FGF), transforming factors, and insulin-like growth factors. Only a few well-controlled, randomized clinical trials have assessed the usefulness of growth factors in healing chronic ulcers, and the results have been largely discrepant. The use of recombinant PDGF was shown to improve diabetic ulcer healing, healing rates, and ulcer size, 101 and to improve healing rates in pressure ulcers, 102, 103 but the use of recombinant FGF was not effective for diabetic ulcers, 104 nor was recombinant EGF effective for venous ulcers. 105 Although no side effects were attributed to the use of growth factors, none of the studies examined costs relative to those of more conservative therapy.
Silver sulfadiazine has been promoted as a wound healing agent and is frequently used in burns, partial thickness wounds, and on skin-graft donor sites. In a randomized, placebo-controlled trial comparing silver sulfadiazine with a tripeptide copper complex and inert petrolatum, silver sulfadiazine was more effective in promoting venous ulcer healing (21% vs 3%) and healing rates at 4 weeks. 106 However, in another 12-week study, silver sulfadiazine did not improve healing rates of venous ulcers as compared with an occlusive dressing or a nonadherent dressing. 90 In this study, 13% of the patients receiving silver sulfadiazine dropped out of the study because of local skin reactions.
Other drugs with potential usefulness are targeted to either enhance fibrinolysis or improve venomotor tone and capillary integrity. Stanazole, an anabolic steroid, stimulates blood fibrinolysis and has been compared with a placebo in the healing of lipodermatosclerosis. Although the healing rate was twice that of the placebo, the results did not reach statistical significance. 107 No adverse clinical effects were noted during the 3-month clinical trial.
Chest-horsenut seed extract stimulates the release of prostaglandins from the F series which mediate venoconstriction 108 and are used in Europe to treat hemorrhoids, varicose veins, and cyclical edema. A randomized clinical trial found chest-horsenut seed extract to be superior to placebo and equivalent to compression stockings in reducing leg volume and edema. 109 Although no adverse clinical effects were reported, its effectiveness and tolerability beyond 12 weeks in CVI are unknown.
Hydroxyethylrutosides have been used in Europe for more than 30 years to treat various types of dependent edema, and have been reviewed by Wadworth and Faulds. 110 They are a standard mixture of semisynthetic flavinoids that act mainly on the microvascular endothelium to reduce permeability and edema. In most placebo-controlled trials, patients receiving hydroxyethylrutosides had reduced leg volume and circumference, and greater relief of pain, night cramps, and restless legs, which persisted up to 4 weeks following discontinuation of treatment. Although all changes were significant, the greatest improvement occurred in patients with the most severe symptoms. When used in the treatment of venous ulcers, results have been equivocal. As compared with a placebo, hydroxyethylrutosides are effective and well tolerated up to 6 months.
SURGERY
Surgery is thought to produce beneficial effects by reducing venous reflux from the deep to the superficial veins or by removing incompetent superficial veins and thereby modifying the effect of venous hypertension on cutaneous tissues. Few of the surgical studies are randomized or controlled, and fewer still assess the effect of surgery on important clinical end points such as ulcer healing. The best studies to date suggest a limited role for surgery in the treatment of CVI. One randomized trial compared ligation of incompetent communicating veins with compression stockings and found that surgery improved, but did not normalize, the amount of expelled blood volume from the lower leg following contraction of calf-muscles, but this study was limited to patients with venographic evidence of a previous DVT. 111 These results correlate with the finding of reduced ulcer recurrence in patients undergoing ligation of incompetent perforators who did not have venographic evidence of DVT. 68 Another trial of ligating incompetent perforating veins with or without skin grafting and compression therapy compared with compression therapy alone demonstrated no increase in healed ulcers, ulcer healing rate, ulcer size, or pain relief. 112 However, patients were not stratified according to presence of previous DVT, and incompetent superficial veins were not removed.
DISCUSSION
Chronic venous insufficiency is a common problem in the primary care setting and is associated with significant morbidity and health-care costs. Patients may be asymptomatic with only minor cosmetic concerns or may be plagued with leg achiness, heaviness, and cramping associated with edema, chronic eczema, pigmentation, fibrosis, and ulceration. The 
